Literature DB >> 15760702

What lessons can be drawn from tuberculosis (TB) control in China in the 1990s? An analysis from a health system perspective.

Shenglan Tang1, Stephen Bertel Squire.   

Abstract

China has made a significant achievement in tackling the TB epidemic over the last decade, due largely to the implementation of directly-observed treatment strategy (DOT). The cure rate of TB cases reached more than 90% for registered TB patients. However, the case detection rate has, unfortunately, been very low (some 30%). Using available information, this paper identifies four main problems facing TB control in China, these are, low case finding, a substantial proportion of TB patients failing to complete standardised treatment, increased proportion of MDR TB patients, and lack of effective TB control among "floating populations". The paper also analyses the possible causes of these problems associated with socio-economic barriers in care seeking, ineffectiveness of TB services, particularly in poor areas, lack of co-operation between health facilities, and weakness of political and financial commitments of local governments to TB control. The paper ends with the discussion of opportunities and challenges facing TB control and makes recommendations for further actions and research.

Entities:  

Mesh:

Year:  2005        PMID: 15760702     DOI: 10.1016/j.healthpol.2004.06.009

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  27 in total

1.  Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype.

Authors:  Igor Mokrousov; Wei Wei Jiao; Gui Zhi Sun; Jia Wen Liu; Violeta Valcheva; Mo Li; Olga Narvskaya; A Dong Shen
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

2.  Evaluation of the rpoB macroarray assay to detect rifampin resistance in Mycobacterium tuberculosis in Beijing, China.

Authors:  I Mokrousov; W W Jiao; G Z Sun; J W Liu; M Li; O Narvskaya; A D Shen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

3.  Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study.

Authors:  Xianqin Ai; Ke Men; Liujia Guo; Tianhua Zhang; Yan Zhao; Xiaolu Sun; Hongwei Zhang; Guangxue He; Marieke J van der Werf; Susan van den Hof
Journal:  BMC Public Health       Date:  2010-03-07       Impact factor: 3.295

4.  Factors associated with health-seeking behavior among migrant workers in Beijing, China.

Authors:  Yingchun Peng; Wenhu Chang; Haiqing Zhou; Hongpu Hu; Wannian Liang
Journal:  BMC Health Serv Res       Date:  2010-03-19       Impact factor: 2.655

5.  The political economy of healthcare reform in China: negotiating public and private.

Authors:  Arthur Daemmrich
Journal:  Springerplus       Date:  2013-09-10

6.  Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.

Authors:  Shelley E Haydel
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-01

Review 7.  Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review.

Authors:  Qian Long; Helen Smith; Tuohong Zhang; Shenglan Tang; Paul Garner
Journal:  BMC Public Health       Date:  2011-05-26       Impact factor: 3.295

8.  Effects of smoking and solid-fuel use on COPD, lung cancer, and tuberculosis in China: a time-based, multiple risk factor, modelling study.

Authors:  Hsien-Ho Lin; Megan Murray; Ted Cohen; Caroline Colijn; Majid Ezzati
Journal:  Lancet       Date:  2008-10-03       Impact factor: 79.321

9.  Communicable disease control in China: From Mao to now.

Authors:  David Hipgrave
Journal:  J Glob Health       Date:  2011-12       Impact factor: 4.413

10.  Comparing patient care seeking pathways in three models of hospital and TB programme collaboration in China.

Authors:  Xiaolin Wei; Guanyang Zou; Jia Yin; John Walley; Qiang Sun
Journal:  BMC Infect Dis       Date:  2013-02-20       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.